医薬品およびCMO(医薬品製造受託機関)のラテンアメリカ市場:産業分析、市場規模、市場シェア、成長、動向、予測

◆英語タイトル:Pharmaceutical Products and CMO Market - Latin America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
◆商品コード:TMR60957
◆発行会社(調査会社):Transparency Market Research
◆発行日:2016年8月31日
◆ページ数:156
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:ラテンアメリカ
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single UserUSD3,395 ⇒換算¥376,845見積依頼/購入/質問フォーム
Multi UserUSD4,395 ⇒換算¥487,845見積依頼/購入/質問フォーム
Corporate LicenseUSD5,395 ⇒換算¥598,845見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規販売代理店です。Transparency Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

This report on the pharmaceutical products and CMO market analyzes the current and future market scenario in Latin America. Most pharmaceutical companies are gradually outsourcing manufacturing activities to contract manufacturers in order to achieve efficiencies in cost, quality, capacity, and time to market or to obtain specific expertise in particular business category, which is not available in-house. Moreover, increasing cost pressures, cost benefits, and inclination of pharmaceutical companies to focus on core competencies such as R&D and marketing has created a need for pharmaceutical contract manufacturing outsourcing.
The Latin America pharmaceutical products and CMO market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to the segments based on product type and countries. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises Porters Five Forces Analysis for the CMO market in order to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by country, thus presenting a thorough analysis of the overall competitive scenario in the pharmaceutical products and CMO market in Latin America.

Based on product type, the market has been segmented into API and ingredients, finished dosage form (FDF), and pharmaceutical packaging. The market segments have been extensively analyzed based on available approved drugs, prevalence of the diseases, available patent of drugs, regulatory access, and geographical coverage in LATAM. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Geographically, the pharmaceutical products and CMO market in Latin America has been categorized into five major countries: Brazil, Mexico, Argentina, Venezuela, and Rest of Latin America. The market size and forecast for each of these countries have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the pharmaceutical and CMO market in the region based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Bayer AG, Novartis AG, Merck & Co., Inc., GSK plc, F. Hofmann La Roche, BASF SE, Boehringer Ingelheim Group, Pisa Farmacéutica, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, Ferring Pharmaceuticals, and Inc., Landsteiner Scientific.

The pharmaceutical products and CMO Market in Latin America has been segmented as given below:

LATAM Pharmaceutical Products and CMO Market, by Product Type

API and Ingredients
Finished Dosage Form (FDF)
Pharmaceutical Packaging
LATAM Pharmaceutical Products and CMO Market, by Country

Brazil
API and Ingredients
Finished Dosage Form (FDF)
Pharmaceutical Packaging
Mexico
API and Ingredients
Finished Dosage Form (FDF)
Pharmaceutical Packaging
Venezuela
API and Ingredients
Finished Dosage Form (FDF)
Pharmaceutical Packaging
Argentina
API and Ingredients
Finished Dosage Form (FDF)
Pharmaceutical Packaging
Rest of Latin America
API and Ingredients
Finished Dosage Form (FDF)
Pharmaceutical Packaging

【レポートの目次】

Section 1 Preface
1.1 Report Scope
1.2 Research Objective

Section 2 Assumptions and Research Methodology

Section 3 Executive Summary

Section 4 Market Overview
4.1 Product Overview
4.2 Key Industry Developments
4.3 Contract Manufacturing Regulations

Section 5 Market Dynamics
5.1 Drivers – Pharmaceutical Products Market
5.2 Restraints – Pharmaceutical Products Market
5.3 Opportunities – Pharmaceutical Products Market
5.4 Drivers – CMO Market
5.5 Restraints – CMO Market
5.6 Opportunities – CMO Market
5.7 Opportunity Analysis
5.8 Porter’s Analysis
5.9 Value Chain Analysis

Section 6 LATAM Pharmaceutical Products and CMO Market Analysis, by Product Type
6.1 Key Findings
6.2 Introduction
6.3 LATAM Pharmaceutical Products Market Value Share Analysis By Product Type, 2015 and 2024
6.4 LATAM Pharmaceutical Products Market Size (US$ Mn) Forecast By Product Type, 2014–2024
6.5 LATAM Pharmaceutical Products Market Analysis, by Product Type (1/7)
6.6 LATAM Pharmaceutical Products Market Attractiveness Analysis, by Product Type
6.7 LATAM CMO Market Size (US$ Mn) Forecast By Product Type, 2014–2024
6.8 Latin America CMO Market Value Share Analysis By Product Type, 2015 and 2024
6.9 LATAM CMO Market Analysis, by Product Type
6.10 LATAM CMO Market Attractiveness Analysis, by Product Type
6.11 Key Trends

Section 7 LATAM Pharmaceutical Products and CMO Market Analysis, by Country
7.1 Latin America Pharmaceutical Products Market Value Share Analysis, by Country
7.2 Pharmaceutical Products Market Forecast, by Country
7.3 Pharmaceutical Products Market Attractiveness Analysis, by Country, 2015
7.4 Latin America CMO Market Value Share Analysis, by Country, 2015 and 2024
7.5 Latin America CMO Market Forecast, by Country

Section 8 Mexico Pharmaceutical Products and CMO Market Analysis
8.1 Key Findings
8.2 Mexico Pharmaceutical Products Market Overview
8.3 Mexico Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
8.4 Mexico Market Forecast, by Product
8.5 Mexico Market Attractiveness Analysis
8.6 Mexico CMO Market Overview
8.7 Mexico CMO Market Value Share Analysis, by Product, 2015 and 2024
8.8 Mexico CMO Market Forecast, by Product
8.9 Mexico CMO Market Attractiveness Analysis, by Product, 2015
8.10 Market Trends

Section 9 Brazil Pharmaceutical Products and CMO Market Analysis
9.1 Key Findings
9.2 Brazil Pharmaceutical Products Market Overview
9.3 Brazil Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
9.4 Brazil Market Forecast, by Product
9.5 Brazil Market Attractiveness Analysis
9.6 Brazil CMO Market Overview
9.7 Brazil CMO Market Value Share Analysis, by Product, 2015 and 2024
9.8 Brazil CMO Market Forecast, by Product
9.9 Brazil CMO Market Attractiveness Analysis, by Product, 2015
9.10 Market Trends

Section 10 Venezuela Pharmaceutical Products and CMO Market Analysis
10.1 Key Findings
10.2 Venezuela Pharmaceutical Products Market Overview
10.3 Venezuela Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
10.4 Venezuela Market Forecast, by Product
10.5 Venezuela Market Attractiveness Analysis
10.6 Venezuela CMO Market Overview
10.7 Venezuela CMO Market Value Share Analysis, by Product, 2015 and 2024
10.8 Venezuela CMO Market Forecast, by Product
10.9 Venezuela CMO Market Attractiveness Analysis, by Product, 2015
10.10 Market Trends

Section 11 Argentina Pharmaceutical Products and CMO Market Analysis
11.1 Key Findings
11.2 Argentina Pharmaceutical Products Market Overview
11.3 Argentina Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
11.4 Argentina Market Forecast, by Product
11.5 Argentina Market Attractiveness Analysis
11.6 Argentina CMO Market Overview
11.7 Argentina CMO Market Value Share Analysis, by Product, 2015 and 2024
11.8 Argentina CMO Market Forecast, by Product
11.9 Argentina CMO Market Attractiveness Analysis, by Product, 2015
11.10 Market Trends

Section 12 Rest of Latin America Pharmaceutical Products and CMO Market Analysis
12.1 Key Findings
12.2 Rest of Latin America Pharmaceutical Products Market Overview
12.3 Rest of Latin America Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
12.4 Rest of Latin America Market Forecast, by Product
12.5 Rest of Latin America Market Attractiveness Analysis
12.6 Rest of Latin America CMO Market Overview
12.7 Rest of Latin America CMO Market Value Share Analysis, by Product, 2015 and 2024
12.8 Rest of Latin America CMO Market Forecast, by Product
12.9 Rest of Latin America CMO Market Attractiveness Analysis, by Product, 2015
12.10 Market Trends

Section 13 Company Profiles
13.1 Competition Matrix
13.2 BASF SE
13.2.1 Company Overview (HQ, Business Segments, Employee Strength)
13.2.2 Financial Overview
13.2.3 Product Portfolio
13.2.4 SWOT Analysis
13.2.5 Strategic Overview
13.3 Bayer AG
13.3.1 Company Overview (HQ, Business Segments, Employee Strength)
13.3.2 Financial Overview
13.3.3 Product Portfolio
13.3.4 SWOT Analysis
13.3.5 Strategic Overview
13.4 Boehringer Ingelheim GmbH
13.4.1 Company Overview (HQ, Business Segments, Employee Strength)
13.4.2 Financial Overview
13.4.3 Product Portfolio
13.4.4 SWOT Analysis
13.4.5 Strategic Overview
13.5 F. Hoffmann-La Roche Ltd.
13.5.1 Company Overview (HQ, Business Segments, Employee Strength)
13.5.2 Financial Overview
13.5.3 Product Portfolio
13.5.4 SWOT Analysis
13.5.5 Strategic Overview
13.6 Merck & Co., Inc.
13.6.1 Company Overview (HQ, Business Segments, Employee Strength)
13.6.2 Financial Overview
13.6.3 Product Portfolio
13.6.4 SWOT Analysis
13.6.5 Strategic Overview
13.7 Novartis AG
13.7.1 Company Overview (HQ, Business Segments, Employee Strength)
13.7.2 Financial Overview
13.7.3 Product Portfolio
13.7.4 SWOT Analysis
13.7.5 Strategic Overview
13.8 Pfizer, Inc.
13.8.1 Company Overview (HQ, Business Segments, Employee Strength)
13.8.2 Financial Overview
13.8.3 Product Portfolio
13.8.4 SWOT Analysis
13.8.5 Strategic Overview
13.9 Pisa Farmacéutica
13.9.1 Company Overview (HQ, Business Segments, Employee Strength)
13.9.2 Financial Overview
13.9.3 Product Portfolio
13.9.4 SWOT Analysis
13.9.5 Strategic Overview
13.10 Fresenius SE & Co. KGaA
13.10.1 Company Overview (HQ, Business Segments, Employee Strength)
13.10.2 Financial Overview
13.10.3 Product Portfolio
13.10.4 SWOT Analysis
13.10.5 Strategic Overview
13.11 Takeda Pharmaceutical Company Limited
13.11.1 Company Overview (HQ, Business Segments, Employee Strength)
13.11.2 Financial Overview
13.11.3 Product Portfolio
13.11.4 SWOT Analysis
13.11.5 Strategic Overview
13.12 Ferring Pharmaceuticals, Inc.
13.12.1 Company Overview (HQ, Business Segments, Employee Strength)
13.12.2 Financial Overview
13.12.3 Product Portfolio
13.12.4 SWOT Analysis
13.12.5 Strategic Overview
13.13 Landsteiner Scientific
13.13.1 Company Overview (HQ, Business Segments, Employee Strength)
13.13.2 Financial Overview
13.13.3 Product Portfolio
13.13.4 SWOT Analysis
13.13.5 Strategic Overview

List of Figures

FIG. 1 LATAM Pharmaceutical Products Market Value Share Analysis, by Product Type, 2015 and 2024
FIG. 2 LATAM API and Ingredients Market Revenue (US$ Mn), 2014–2024
FIG. 3 LATAM Finished Dosage Form Market Revenue (US$ Mn), 2014–2024
FIG. 4 LATAM Pharmaceutical Packaging Market Revenue (US$ Mn), 2014–2024
FIG. 5 LATAM Pharmaceutical Products Market Attractiveness Analysis, by Product Type
FIG. 6 LATAM CMO Market Value Share Analysis By Product Type, 2015 and 2024
FIG. 7 LATAM API and Ingredients Market Revenue (US$ Mn), 2014–2024
FIG. 8 LATAM API and Ingredients Market Revenue (US$ Mn), 2014–2024
FIG. 9 LATAM Pharmaceutical Packaging Market Revenue (US$ Mn), 2014–2024
FIG. 10 LATAM CMO Market Attractiveness Analysis, by Product Type
FIG. 11 Latin America Pharmaceutical Products Market Value Share Analysis, by Country, 2015 and 2024
FIG. 12 Pharmaceutical Products Market Attractiveness Analysis, by Country, 2015
FIG. 13 Latin America Market Value Share Analysis,
FIG. 14 Mexico Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014–2024
FIG. 15 Mexico Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
FIG. 16 Mexico Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
FIG. 17 Mexico CMO Market Size (US$ Mn) Forecast, 2014–2024
FIG. 18 Mexico CMO Market Attractiveness Analysis, by Product
FIG. 19 Mexico CMO Market Value Share Analysis, by Product, 2015 and 2024
FIG. 20 Mexico CMO Market Attractiveness Analysis, By Product, 2015
FIG. 21 Brazil Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014–2024
FIG. 22 Brazil Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
FIG. 23 Brazil Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
FIG. 24 Brazil CMO Market Size (US$ Mn) Forecast, 2016–2024
FIG. 25 Brazil CMO Market Value Share Analysis, by Product, 2015 and 2024
FIG. 26 Brazil Market Attractiveness Analysis, by Product, 2015
FIG. 27 Venezuela Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014–2024
FIG. 28 Venezuela Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
FIG. 29 Venezuela Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
FIG. 30 Venezuela CMO Market Size (US$ Mn) Forecast, 2016–2024
FIG. 31 Venezuela CMO Market Value Share Analysis, by Product, 2015 and 2024
FIG. 32 Venezuela CMO Market Attractiveness Analysis, by Product, 2015 and 2024
FIG. 33 Argentina Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014–2024
FIG. 34 Argentina Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
FIG. 35 Argentina Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
FIG. 36 Argentina CMO Market Size (US$ Mn) Forecast, 2016–2024
FIG. 37 Argentina CMO Market Value Share Analysis,
FIG. 38 Argentina Market Attractiveness Analysis, by Product, 2015
FIG. 39 Rest of LATAM Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014–2024
FIG. 40 Rest of LATAM Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
FIG. 41 Rest of LATAM Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
FIG. 42 Rest of LATAM CMO Market Value Share Analysis,
FIG. 43 Rest of LATAM Market Attractiveness Analysis, by Product, 2015

List of Tables

TABLE 1 LATAM Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 2 LATAM CMO Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 3 Latin America Pharmaceutical Products Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 4 Latin America Pharmaceutical Products Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 5 Mexico Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014–2024
TABLE 6 Mexico CMO Market Size (US$ Mn) Forecast, by Product, 2016–2024
TABLE 7 Brazil Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014–2024
TABLE 8 Brazil CMO Market Size (US$ Mn) Forecast, by Product, 2016–2024
TABLE 9 Venezuela Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014–2024
TABLE 10 Venezuela CMO Market Size (US$ Mn) Forecast, by Product, 2016–2024
TABLE 11 Argentina Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014–2024
TABLE 12 Argentina CMO Market Size (US$ Mn) Forecast, by Product, 2016–2024
TABLE 13 Rest of LATAM Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014–2024
TABLE 14 Rest of LATAM CMO Market Size (US$ Mn) Forecast, by Product, 2016–2024



【レポートのキーワード】

医薬品およびCMO(医薬品製造受託機関)

★調査レポート[医薬品およびCMO(医薬品製造受託機関)のラテンアメリカ市場:産業分析、市場規模、市場シェア、成長、動向、予測]販売に関する免責事項
★調査レポート[医薬品およびCMO(医薬品製造受託機関)のラテンアメリカ市場:産業分析、市場規模、市場シェア、成長、動向、予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆